Stellar Biotechnologies


WKN: A2PL1Q | Symbol: EDSA
2,120
$
22:30:00
Nasdaq
+4,43 %
+0,090 USD

Beitrag schreiben

Begriffe und/oder Benutzer

 

hab nach Jahren wieder mal reingeschaut:

"The net loss for the fiscal year ended September 30, 2015 was $2.8 million, or ($0.36) per share, as compared to a net loss of $8.4 million, or ($1.11) per share, for the fiscal year 2014."

die bottom line des 2015er reports v. 14 Dez sieht ja nicht so toll aus...

LG
keyar
aus dem Q III Report:
. The net loss for the nine months ended June 30, 2016 was $3.68 million, or ($0.44) per basic share, as compared to a net loss of $1.3 million, or ($0.16) per basic share, for the nine months ended June 30, 2015.

LG
keyar


Beitrag zu dieser Diskussion schreiben